#USA #San Diego #Avimer Bio #CNIO #Protein Cages

Avimer Bio and CNIO's Revolutionary Protein Cage Design

Avimer Bio, in partnership with the Spanish National Cancer Research Centre (CNIO), has recently published groundbreaking research in the Journal of the American Chemical Society detailing their innovative methods for designing self-assembling protein cages with utmost atomic precision. This publication reflects significant strides towards overcoming one of the key challenges in protein design—the ability to create assemblies with predictable shapes.

The team, led by Chief Scientific Officer Todd Yeates at UCLA, previously introduced geometric methods for crafting protein cage nanoparticles. However, the earlier approaches required exceptionally precise shapes, making the inherent versatility of protein structures a significant challenge. To tackle this issue, the team developed advanced computer algorithms that can accurately predict the bending behavior of spiral-shaped protein segments known as alpha helices. This innovation leverages the natural flexibility of proteins, yielding cubic protein cages with small mutations to four trimeric building blocks, encompassing twelve subunits in total and achieving molecular masses exceeding 600 kilodaltons while maintaining their stability in solution.

Technical Innovations

Todd Yeates elaborated, "Protein cages must fit together several subunits in very specific configurations. We utilized mathematical strategies and mechanical design principles to identify architectures that utilize the proteins' natural flexibility, allowing them to adopt the necessary shapes for assembly. By combining these methodologies with contemporary AI techniques, we can design around that flexibility, paving the way for novel therapeutic protein assemblies." This combination of innovations signifies a potential shift in targeted therapeutic approaches, harnessing the use of protein assemblies for more efficient treatments.

Structural Validation

To validate their designs, the CNIO team in Madrid utilized high-resolution cryo-electron microscopy. Led by Pablo San Segundo-Acosta and Roger Castells-Graells, this technology confirmed that the physical structures of the protein cages corresponded remarkably with the computational models, achieving resolutions ranging from 3.0 to 3.9 angstroms, with discrepancies between the predicted models and actual structures maintained at a minimal 2 angstroms along the protein backbone. These findings verified the accuracy of the helix bending proportions predicted by the algorithms.

Clinical Relevance and Benefits

The applications of these designed protein cages are vast, presenting a multitude of therapeutic benefits. They can position numerous therapeutic proteins in controlled arrangements to effectively engage cell receptors—facilitating the activation of specific signaling pathways often reliant on receptor clustering. Traditional antibodies typically possess two binding arms; however, these programmable cages can orchestrate the necessary grouping of receptors, enabling novel therapeutic strategies.

Noteworthy potential applications include managing autoimmune diseases such as rheumatoid arthritis and ulcerative colitis, where engaging designated immune cells is crucial for modulating inflammation. In the field of oncology, therapeutic proteins attached to a cage can effectively gather receptors that stimulate immune cells, encouraging them to target and destroy tumors.

Unique Features of the Platform

This innovative platform is characterized by two main attributes:
1. Minimal Changes to Natural Protein Sequences: The design approach retains much of the original protein sequence. When applied to human proteins, it enhances designs that exhibit high similarity to natural human proteins, which is advantageous for evaluating immune responses.
2. Single Protein Subunit Composition: Each cage is constructed from a single type of protein subunit. This not only simplifies production but also ensures consistent composition, unlike particles requiring multiple distinct chains.

Research Team and Future Directions

The design efforts at Avimer Bio were spearheaded by Robin Aglietti and Peter Bowers under Todd Yeates’ guidance. The structural biology insights provided by Roger Castells-Graells at CNIO were crucial during the cryo-electron microscopy evaluations.

The full study, titled "Design and Structure of Protein Cages Based on Helical Fusion and Machine Learning," is published in JACS, accessible at https://doi.org/10.1021/jacs.6c11491.

About Avimer Bio

Avimer Bio specializes in crafting programmable protein architectures aimed at targeted therapeutics. Based in San Diego, the company develops cutting-edge computational strategies for creating protein assemblies that streamline interactions between therapeutic molecules and cell receptors. To learn more, visit www.avimerbio.com.